Angiogenin‐mediated tRNA cleavage as a novel feature of stored red blood cells

Abstract

treatment outcome in classical Hodgkin’s lymphoma: a retrospective, European, multicentre cohort study. The Lancet Haematology, 3, e467– e479. Borchmann, P., Goergen, H., Kobe, C., Lohri, A., Greil, R., Eichenauer, D.A., Zijlstra, J.M., Markova, J., Meissner, J., Feuring-Buske, M., Huttmann, A., Dierlamm, J., Soekler, M., Beck, H.J., Willenbacher, W., Ludwig, W.D., Pabst, T., Topp, M.S., Hitz, F., Bentz, M., Keller, U.B., Kuhnhardt, D., Ostermann, H., Schmitz, N., Hertenstein, B., Aulitzky, W., Maschmeyer, G., Vieler, T., Eich, H., Baues, C., Stein, H., Fuchs, M., Kuhnert, G., Diehl, V., Dietlein, M. & Engert, A. (2018) PETguided treatment in patients with advanced-stage Hodgkin’s lymphoma (HD18): final results of an open-label, international, randomised phase 3 trial by the German Hodgkin Study Group. Lancet, 390, 2790–2802. Casasnovas, R.O., Meignan, M., Berriolo-Riedinger, A., Bardet, S., Julian, A., Thieblemont, C., Vera, P., Bologna, S., Briere, J., Jais, J.P., Haioun, C., Coiffier, B. & Morschhauser, F. (2011) SUVmax reduction improves early prognosis value of interim positron emission tomography scans in diffuse large B-cell lymphoma. Blood, 118, 37–43. El-Galaly, T.C., Mylam, K.J., Brown, P., Specht, L., Christiansen, I., Munksgaard, L., Johnsen, H.E., Loft, A., Bukh, A., Iyer, V., Nielsen, A.L. & Hutchings, M. (2012) Positron emission tomography/computed tomography surveillance in patients with Hodgkin lymphoma in first remission has a low positive predictive value and high costs. Haematologica, 97, 931–936. Gallamini, A., Hutchings, M., Rigacci, L., Specht, L., Merli, F., Hansen, M., Patti, C., Loft, A., Di Raimondo, F., D’Amore, F., Biggi, A., Vitolo, U., Stelitano, C., Sancetta, R., Trentin, L., Luminari, S., Iannitto, E., Viviani, S., Pierri, I. & Levis, A. (2007) Early interim 2-[18F]fluoro-2deoxy-D-glucose positron emission tomography is prognostically superior to international prognostic score in advanced-stage Hodgkin’s lymphoma: a report from a joint Italian-Danish study. Journal of Clinical Oncology, 25, 3746– 3752. Gallamini, A., Barrington, S.F., Biggi, A., Chauvie, S., Kostakoglu, L., Gregianin, M., Meignan, M., Mikhaeel, G.N., Loft, A., Zaucha, J.M., Seymour, J.F., Hofman, M.S., Rigacci, L., Pulsoni, A., Coleman, M., Dann, E.J., Trentin, L., Casasnovas, O., Rusconi, C., Brice, P., Bolis, S., Viviani, S., Salvi, F., Luminari, S. & Hutchings, M. (2014) The predictive role of interim positron emission tomography for Hodgkin lymphoma treatment outcome is confirmed using the interpretation criteria of the Deauville five-point scale. Haematologica, 99, 1107–1113. Lazarovici, J., Terroir, M., Arfi-Rouche, J., Michot, J.M., Mussot, S., Florea, V., Ghigna, M.R., Dartigues, P., Petrovanu, C., Danu, A., Ferme, C., Ribrag, V. & Ghez, D. (2017) Poor predictive value of positive interim FDG-PET/CT in primary mediastinal large B-cell lymphoma. European Journal of Nuclear Medicine and Molecular Imaging, 44, 2018–2024. Moskowitz, C.H., Schoder, H., Teruya-Feldstein, J., Sima, C., Iasonos, A., Portlock, C.S., Straus, D., Noy, A., Palomba, M.L., O’Connor, O.A., Horwitz, S., Weaver, S.A., Meikle, J.L., Filippa, D.A., Caravelli, J.F., Hamlin, P.A. & Zelenetz, A.D. (2010) Risk-adapted dose-dense immunochemotherapy determined by interim FDG-PET in advanced-stage diffuse large B-cell lymphoma. Journal of Clinical Oncology, 28, 1896–1903. Pileri, S.A., Ascani, S., Leoncini, L., Sabattini, E., Zinzani, P.L., Piccaluga, P.P., Pileri, A. Jr, Giunti, M., Falini, B., Bolis, G.B. & Stein, H. (2002) Hodgkin’s lymphoma: the pathologist’s viewpoint. Journal of Clinical Pathology, 55, 162–176. Schoder, H., Zelenetz, A.D., Hamlin, P., Gavane, S., Horwitz, S., Matasar, M., Moskowitz, A., Noy, A., Palomba, L., Portlock, C., Straus, D., Grewal, R., Migliacci, J.C., Larson, S.M. & Moskowitz, C.H. (2016) Prospective study of 30Deoxy-30-18F-Fluorothymidine PET for early interim response assessment in advanced-stage B-cell lymphoma. Journal of Nuclear Medicine, 57, 728–734.